Virginia Must Extend Deadline to Review Next Era-Dominion Merger

The Virginia Distributed Alliance and Secure Solar Futures Urge Gov. Spanberger and the General Assembly to Allow 12 Months to Examine Complex Mega Merger and Ensure Adequate Protection for Ratepayers

The Virginia Distributed Alliance and Secure Solar Futures Urge Gov. Spanberger and the General Assembly to Allow 12 Months to Examine Complex Mega Merger and Ensure Adequate Protection for Ratepayers

New Mexico Bioscience Delegation Showcases Innovation and Industry Growth at BIO International Convention 2026

Albuquerque, NM, June 18, 2026 (GLOBE NEWSWIRE) — A delegation of economic development, research, healthcare, and industry leaders will represent New Mexico’s growing bioscience sector at the BIO International Convention, taking place June 22–25, 2026, in San Diego, California. Led by the Albuquerque Regional Economic Alliance (AREA), the delegation will promote New Mexico’s bioscience industry, highlight the state’s innovation ecosystem, and connect with companies, investors, and industry leaders from around the globe.

Independent Bank Corporation Announces Shareholder Approval to Acquire HCB Financial Corp. and Highpoint Community Bank

GRAND RAPIDS, Mich., and HASTINGS, Mich., June 18, 2026 (GLOBE NEWSWIRE) — Independent Bank Corporation (NASDAQ: IBCP), the parent company of Independent Bank, with total assets of approximately $5.5 billion, and HCB Financial Corp. (“HCB”), the parent company of Highpoint Community Bank, with total assets of approximately $590 million, previously announced the signing of a definitive merger agreement on March 18, 2026 for IBCP to acquire HCB.

Age-related Macular Degeneration Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 90+ Leading Players Wheeling the Therapeutics Landscape

The age-related macular degeneration clinical trial analysis report delivers important insights into ongoing research of 100+ pipeline age-related macular degeneration drugs, clinical strategies, upcoming therapeutics, and commercial analysis.

The age-related macular degeneration clinical trial analysis report delivers important insights into ongoing research of 100+ pipeline age-related macular degeneration drugs, clinical strategies, upcoming therapeutics, and commercial analysis.

Global Cell and Gene Therapy CDMO Market Anticipating Remarkable Growth at a CAGR of ~24% by 2034 | DelveInsight

The cell and gene therapy CDMO market is experiencing significant growth, driven by the increasing number of cell and gene therapy candidates advancing through clinical development and commercialization. Rising investments in regenerative medicine, CAR-T therapies, gene editing technologies, and rare disease treatments are fueling demand for specialized manufacturing services. Pharmaceutical and biotechnology companies are increasingly partnering with CDMOs to access advanced manufacturing capabilities, reduce production costs, and accelerate time-to-market. Additionally, ongoing technological advancements in viral vector production, cell processing, and scalable manufacturing platforms are further supporting market expansion. As the CGT pipeline continues to mature globally, the need for experienced CDMO partners is expected to grow substantially over the coming years.

The cell and gene therapy CDMO market is experiencing significant growth, driven by the increasing number of cell and gene therapy candidates advancing through clinical development and commercialization. Rising investments in regenerative medicine, CAR-T therapies, gene editing technologies, and rare disease treatments are fueling demand for specialized manufacturing services. Pharmaceutical and biotechnology companies are increasingly partnering with CDMOs to access advanced manufacturing capabilities, reduce production costs, and accelerate time-to-market. Additionally, ongoing technological advancements in viral vector production, cell processing, and scalable manufacturing platforms are further supporting market expansion. As the CGT pipeline continues to mature globally, the need for experienced CDMO partners is expected to grow substantially over the coming years.

TOPDON ONE Plus Ushers in New Standard of Auto Repair Technology for Professional Repair Shops, Diagnostic Specialists

ROCKAWAY, NEW JERSEY, June 18, 2026 (GLOBE NEWSWIRE) — TOPDON USA (https://www.topdon.us), a leading provider of cutting-edge diagnostic tools, technology, and software solutions for DIY and automotive repair professionals, is setting the new diagnostics standard with the TOPDON ONE Plus (https://www.topdon.us/products/one-plus). Offering advanced Electronic Control Unit (ECU) programming and coding for more than 50 essential service functions, the new TOPDON ONE Plus is an advanced software solution designed to tackle the most challenging auto service and repair diagnostics. The TOPDON ONE PLUS kit also includes a TopScan Master and BTMobile ProS, expanding diagnostic coverage and wireless testing capability right out of the box. The TOPDON ONE Plus is now available through TOPDON’s national distribution network.

Keystone Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing on or about June 22, 2026.

New York, New York, June 18, 2026 (GLOBE NEWSWIRE) — Keystone Acquisition Corp. (Nasdaq: KEYYU) (the “Company”) announced that holders of the units sold in the Company’s initial public offering of 28,750,000 units, which includes 3,750,000 units issued pursuant to the exercise by the underwriters of their overallotment option in full, completed on June 4, 2026 (the “Offering”), may elect to separately trade the Class A ordinary shares and warrants included in the units commencing on or about June 22, 2026. Any units not separated will continue to trade on The Nasdaq Global Market under the symbol “KEYYU,” and each of the Class A ordinary shares and warrants will separately trade on The Nasdaq Global Market under the symbols “KEYY” and “KEYYW,” respectively. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Holders of units will need to have their brokers contact Efficiency INC., the Company’s transfer agent, in order to separate the units into Class A ordinary shares and warrants.

Forefront Tech Holdings Acquisition Corp Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing June 22, 2026

GRAND CAYMAN, CAYMAN ISLANDS, June 18, 2026 (GLOBE NEWSWIRE) — Forefront Tech Holdings Acquisition Corp (NASDAQ: FTHAU) (the “Company”) today announced that commencing June 22, 2026, holders of the units sold in its initial public offering (the “Units”) may elect to separately trade the Class A ordinary shares and warrants included in the Units. Each Unit consists of one Class A ordinary share and one-half of one redeemable warrant. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share. Only whole warrants are exercisable.

XTB Group Consolidates B2B Operations as X Open Hub Transitions to XTB Institutional

Warsaw, Poland, June 18, 2026 (GLOBE NEWSWIRE) — XTB Group has announced the rebranding of its B2B liquidity and execution division, previously operating as X Open Hub, to XTB Institutional. The transition aligns the institutional business more closely with the XTB brand and will be formally presented to industry participants at iFX EXPO International 2026 in Limassol, Cyprus.

Veterinary API Manufacturing Market to Reach USD 18.48 Billion by 2035 as Animal Health Investments and Zoonotic Disease Prevention Accelerate – SNS Insider

The U.S. Veterinary API Manufacturing Market was valued at USD 2.02 Billion in 2025 and is projected to reach USD 4.84 Billion by 2035, while Europe is expected to grow from USD 2.02 Billion to USD 4.84 Billion during the forecast period, supported by expanding biologics production, strong regulatory frameworks, and increasing investments in animal healthcare.

The U.S. Veterinary API Manufacturing Market was valued at USD 2.02 Billion in 2025 and is projected to reach USD 4.84 Billion by 2035, while Europe is expected to grow from USD 2.02 Billion to USD 4.84 Billion during the forecast period, supported by expanding biologics production, strong regulatory frameworks, and increasing investments in animal healthcare.

Organic Yogurt Market to Reach USD 22.30 Billion by 2033 as Demand for Cleaner-Label Dairy and Plant-Based Alternatives Accelerates Worldwide: Verified Market Research®

Rising consumer preference for ingredient transparency, functional nutrition, organic certification, and improved cold-chain distribution continues to strengthen long-term growth prospects across the Global Organic Yogurt Market

Rising consumer preference for ingredient transparency, functional nutrition, organic certification, and improved cold-chain distribution continues to strengthen long-term growth prospects across the Global Organic Yogurt Market